Raoul announces $8.3 million settlement over alleged anticompetitive EpiPen practices
Illinois will receive nearly $8.3 million as part of a settlement with an EpiPen manufacturer over concerns it engaged in anticompetitive conduct related to its products.
To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.
